Table of Content

1 Anti Influenza Virus Chinese Medicine Market Overview
1.1 Product Overview and Scope of Anti Influenza Virus Chinese Medicine
1.2 Anti Influenza Virus Chinese Medicine Segment by Type
1.2.1 Global Anti Influenza Virus Chinese Medicine Market Value Comparison by Type (2024-2034)
1.2.2 Oral Solution
1.2.3 Capsule
1.2.4 Lozenges
1.2.5 Chewable Tablets
1.2.6 Aerosol
1.2.7 Injection
1.2.8 Pills
1.2.9 Particles
1.2.10 Syrup
1.3 Anti Influenza Virus Chinese Medicine Segment by Application
1.3.1 Global Anti Influenza Virus Chinese Medicine Market Value by Application: (2024-2034)
1.3.2 Adult
1.3.3 Children
1.4 Global Anti Influenza Virus Chinese Medicine Market Size Estimates and Forecasts
1.4.1 Global Anti Influenza Virus Chinese Medicine Revenue 2018-2029
1.4.2 Global Anti Influenza Virus Chinese Medicine Sales 2018-2029
1.4.3 Global Anti Influenza Virus Chinese Medicine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti Influenza Virus Chinese Medicine Market Competition by Manufacturers
2.1 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Anti Influenza Virus Chinese Medicine Average Price by Manufacturers (2018-2024)
2.4 Global Anti Influenza Virus Chinese Medicine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Anti Influenza Virus Chinese Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti Influenza Virus Chinese Medicine, Product Type & Application
2.7 Anti Influenza Virus Chinese Medicine Market Competitive Situation and Trends
2.7.1 Anti Influenza Virus Chinese Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti Influenza Virus Chinese Medicine Players Market Share by Revenue
2.7.3 Global Anti Influenza Virus Chinese Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti Influenza Virus Chinese Medicine Retrospective Market Scenario by Region
3.1 Global Anti Influenza Virus Chinese Medicine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti Influenza Virus Chinese Medicine Global Anti Influenza Virus Chinese Medicine Sales by Region: 2018-2029
3.2.1 Global Anti Influenza Virus Chinese Medicine Sales by Region: 2018-2024
3.2.2 Global Anti Influenza Virus Chinese Medicine Sales by Region: 2024-2029
3.3 Global Anti Influenza Virus Chinese Medicine Global Anti Influenza Virus Chinese Medicine Revenue by Region: 2018-2029
3.3.1 Global Anti Influenza Virus Chinese Medicine Revenue by Region: 2018-2024
3.3.2 Global Anti Influenza Virus Chinese Medicine Revenue by Region: 2024-2029
3.4 North America Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
3.4.1 North America Anti Influenza Virus Chinese Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti Influenza Virus Chinese Medicine Sales by Country (2018-2029)
3.4.3 North America Anti Influenza Virus Chinese Medicine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
3.5.1 Europe Anti Influenza Virus Chinese Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti Influenza Virus Chinese Medicine Sales by Country (2018-2029)
3.5.3 Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Anti Influenza Virus Chinese Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti Influenza Virus Chinese Medicine Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti Influenza Virus Chinese Medicine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
3.7.1 Latin America Anti Influenza Virus Chinese Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti Influenza Virus Chinese Medicine Sales by Country (2018-2029)
3.7.3 Latin America Anti Influenza Virus Chinese Medicine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti Influenza Virus Chinese Medicine Sales by Type (2018-2029)
4.1.1 Global Anti Influenza Virus Chinese Medicine Sales by Type (2018-2024)
4.1.2 Global Anti Influenza Virus Chinese Medicine Sales by Type (2024-2029)
4.1.3 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2018-2029)
4.2 Global Anti Influenza Virus Chinese Medicine Revenue by Type (2018-2029)
4.2.1 Global Anti Influenza Virus Chinese Medicine Revenue by Type (2018-2024)
4.2.2 Global Anti Influenza Virus Chinese Medicine Revenue by Type (2024-2029)
4.2.3 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2018-2029)
4.3 Global Anti Influenza Virus Chinese Medicine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti Influenza Virus Chinese Medicine Sales by Application (2018-2029)
5.1.1 Global Anti Influenza Virus Chinese Medicine Sales by Application (2018-2024)
5.1.2 Global Anti Influenza Virus Chinese Medicine Sales by Application (2024-2029)
5.1.3 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2018-2029)
5.2 Global Anti Influenza Virus Chinese Medicine Revenue by Application (2018-2029)
5.2.1 Global Anti Influenza Virus Chinese Medicine Revenue by Application (2018-2024)
5.2.2 Global Anti Influenza Virus Chinese Medicine Revenue by Application (2024-2029)
5.2.3 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2018-2029)
5.3 Global Anti Influenza Virus Chinese Medicine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Guangzhou Pharmaceutical
6.1.1 Guangzhou Pharmaceutical Corporation Information
6.1.2 Guangzhou Pharmaceutical Description and Business Overview
6.1.3 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.1.5 Guangzhou Pharmaceutical Recent Developments/Updates
6.2 CR SANJIU
6.2.1 CR SANJIU Corporation Information
6.2.2 CR SANJIU Description and Business Overview
6.2.3 CR SANJIU Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CR SANJIU Anti Influenza Virus Chinese Medicine Product Portfolio
6.2.5 CR SANJIU Recent Developments/Updates
6.3 TASLY
6.3.1 TASLY Corporation Information
6.3.2 TASLY Description and Business Overview
6.3.3 TASLY Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 TASLY Anti Influenza Virus Chinese Medicine Product Portfolio
6.3.5 TASLY Recent Developments/Updates
6.4 China TCM
6.4.1 China TCM Corporation Information
6.4.2 China TCM Description and Business Overview
6.4.3 China TCM Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 China TCM Anti Influenza Virus Chinese Medicine Product Portfolio
6.4.5 China TCM Recent Developments/Updates
6.5 Yunnan Baiyao
6.5.1 Yunnan Baiyao Corporation Information
6.5.2 Yunnan Baiyao Description and Business Overview
6.5.3 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Portfolio
6.5.5 Yunnan Baiyao Recent Developments/Updates
6.6 Tongrentang
6.6.1 Tongrentang Corporation Information
6.6.2 Tongrentang Description and Business Overview
6.6.3 Tongrentang Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Tongrentang Anti Influenza Virus Chinese Medicine Product Portfolio
6.6.5 Tongrentang Recent Developments/Updates
6.7 Jumpcan
6.6.1 Jumpcan Corporation Information
6.6.2 Jumpcan Description and Business Overview
6.6.3 Jumpcan Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Jumpcan Anti Influenza Virus Chinese Medicine Product Portfolio
6.7.5 Jumpcan Recent Developments/Updates
6.8 Zhejiang Conba Pharmaceutical
6.8.1 Zhejiang Conba Pharmaceutical Corporation Information
6.8.2 Zhejiang Conba Pharmaceutical Description and Business Overview
6.8.3 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.8.5 Zhejiang Conba Pharmaceutical Recent Developments/Updates
6.9 Green Valley Pharma
6.9.1 Green Valley Pharma Corporation Information
6.9.2 Green Valley Pharma Description and Business Overview
6.9.3 Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Portfolio
6.9.5 Green Valley Pharma Recent Developments/Updates
6.10 Changbaishan Pharmaceutical
6.10.1 Changbaishan Pharmaceutical Corporation Information
6.10.2 Changbaishan Pharmaceutical Description and Business Overview
6.10.3 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.10.5 Changbaishan Pharmaceutical Recent Developments/Updates
6.11 Zhejiang Kanglaite Pharmaceutical
6.11.1 Zhejiang Kanglaite Pharmaceutical Corporation Information
6.11.2 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.11.3 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.11.5 Zhejiang Kanglaite Pharmaceutical Recent Developments/Updates
6.12 Qingfeng Pharmaceutical Group
6.12.1 Qingfeng Pharmaceutical Group Corporation Information
6.12.2 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Description and Business Overview
6.12.3 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
6.12.5 Qingfeng Pharmaceutical Group Recent Developments/Updates
6.13 Buchang Pharmaceutical
6.13.1 Buchang Pharmaceutical Corporation Information
6.13.2 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.13.3 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.13.5 Buchang Pharmaceutical Recent Developments/Updates
6.14 Livzon
6.14.1 Livzon Corporation Information
6.14.2 Livzon Anti Influenza Virus Chinese Medicine Description and Business Overview
6.14.3 Livzon Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Livzon Anti Influenza Virus Chinese Medicine Product Portfolio
6.14.5 Livzon Recent Developments/Updates
6.15 ZBD Pharmaceutical
6.15.1 ZBD Pharmaceutical Corporation Information
6.15.2 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.15.3 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.15.5 ZBD Pharmaceutical Recent Developments/Updates
6.16 Chase Sun Pharmaceutical
6.16.1 Chase Sun Pharmaceutical Corporation Information
6.16.2 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.16.3 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.16.5 Chase Sun Pharmaceutical Recent Developments/Updates
6.17 Wuzhou Pharmaceutical
6.17.1 Wuzhou Pharmaceutical Corporation Information
6.17.2 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.17.3 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.17.5 Wuzhou Pharmaceutical Recent Developments/Updates
6.18 Yusheng Pharmaceutical
6.18.1 Yusheng Pharmaceutical Corporation Information
6.18.2 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.18.3 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.18.5 Yusheng Pharmaceutical Recent Developments/Updates
6.19 Harbin Pharmaceutical Group
6.19.1 Harbin Pharmaceutical Group Corporation Information
6.19.2 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Description and Business Overview
6.19.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
6.19.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.20 Fusen Pharmaceutical
6.20.1 Fusen Pharmaceutical Corporation Information
6.20.2 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.20.3 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.20.5 Fusen Pharmaceutical Recent Developments/Updates
6.21 Gerun Pharmaceutical
6.21.1 Gerun Pharmaceutical Corporation Information
6.21.2 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.21.3 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.21.5 Gerun Pharmaceutical Recent Developments/Updates
6.22 Shineway Pharmaceutical
6.22.1 Shineway Pharmaceutical Corporation Information
6.22.2 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.22.3 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.22.5 Shineway Pharmaceutical Recent Developments/Updates
6.23 Yiling Pharmaceutical
6.23.1 Yiling Pharmaceutical Corporation Information
6.23.2 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Description and Business Overview
6.23.3 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
6.23.5 Yiling Pharmaceutical Recent Developments/Updates
6.24 Harbin Pharmaceutical Group
6.24.1 Harbin Pharmaceutical Group Corporation Information
6.24.2 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Description and Business Overview
6.24.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
6.24.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti Influenza Virus Chinese Medicine Industry Chain Analysis
7.2 Anti Influenza Virus Chinese Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti Influenza Virus Chinese Medicine Production Mode & Process
7.4 Anti Influenza Virus Chinese Medicine Sales and Marketing
7.4.1 Anti Influenza Virus Chinese Medicine Sales Channels
7.4.2 Anti Influenza Virus Chinese Medicine Distributors
7.5 Anti Influenza Virus Chinese Medicine Customers
8 Anti Influenza Virus Chinese Medicine Market Dynamics
8.1 Anti Influenza Virus Chinese Medicine Industry Trends
8.2 Anti Influenza Virus Chinese Medicine Market Drivers
8.3 Anti Influenza Virus Chinese Medicine Market Challenges
8.4 Anti Influenza Virus Chinese Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti Influenza Virus Chinese Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Anti Influenza Virus Chinese Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Anti Influenza Virus Chinese Medicine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Anti Influenza Virus Chinese Medicine Sales (Kiloton) of Key Manufacturers (2018-2024)
Table 5. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Anti Influenza Virus Chinese Medicine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Anti Influenza Virus Chinese Medicine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Anti Influenza Virus Chinese Medicine Average Price (US$/Ton) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Anti Influenza Virus Chinese Medicine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Anti Influenza Virus Chinese Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti Influenza Virus Chinese Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Anti Influenza Virus Chinese Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti Influenza Virus Chinese Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Influenza Virus Chinese Medicine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti Influenza Virus Chinese Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Anti Influenza Virus Chinese Medicine Sales by Region (2018-2024) & (Kiloton)
Table 18. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2018-2024)
Table 19. Global Anti Influenza Virus Chinese Medicine Sales by Region (2024-2029) & (Kiloton)
Table 20. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2024-2029)
Table 21. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2018-2024)
Table 23. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2024-2029)
Table 25. North America Anti Influenza Virus Chinese Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Anti Influenza Virus Chinese Medicine Sales by Country (2018-2024) & (Kiloton)
Table 27. North America Anti Influenza Virus Chinese Medicine Sales by Country (2024-2029) & (Kiloton)
Table 28. North America Anti Influenza Virus Chinese Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Anti Influenza Virus Chinese Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Anti Influenza Virus Chinese Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2018-2024) & (Kiloton)
Table 32. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2024-2029) & (Kiloton)
Table 33. Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Anti Influenza Virus Chinese Medicine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Anti Influenza Virus Chinese Medicine Sales by Region (2018-2024) & (Kiloton)
Table 37. Asia Pacific Anti Influenza Virus Chinese Medicine Sales by Region (2024-2029) & (Kiloton)
Table 38. Asia Pacific Anti Influenza Virus Chinese Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Anti Influenza Virus Chinese Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Anti Influenza Virus Chinese Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Anti Influenza Virus Chinese Medicine Sales by Country (2018-2024) & (Kiloton)
Table 42. Latin America Anti Influenza Virus Chinese Medicine Sales by Country (2024-2029) & (Kiloton)
Table 43. Latin America Anti Influenza Virus Chinese Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Anti Influenza Virus Chinese Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Country (2018-2024) & (Kiloton)
Table 47. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Country (2024-2029) & (Kiloton)
Table 48. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Anti Influenza Virus Chinese Medicine Sales (Kiloton) by Type (2018-2024)
Table 51. Global Anti Influenza Virus Chinese Medicine Sales (Kiloton) by Type (2024-2029)
Table 52. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2018-2024)
Table 53. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2024-2029)
Table 54. Global Anti Influenza Virus Chinese Medicine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Anti Influenza Virus Chinese Medicine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2018-2024)
Table 57. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2024-2029)
Table 58. Global Anti Influenza Virus Chinese Medicine Price (US$/Ton) by Type (2018-2024)
Table 59. Global Anti Influenza Virus Chinese Medicine Price (US$/Ton) by Type (2024-2029)
Table 60. Global Anti Influenza Virus Chinese Medicine Sales (Kiloton) by Application (2018-2024)
Table 61. Global Anti Influenza Virus Chinese Medicine Sales (Kiloton) by Application (2024-2029)
Table 62. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2018-2024)
Table 63. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2024-2029)
Table 64. Global Anti Influenza Virus Chinese Medicine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Anti Influenza Virus Chinese Medicine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2018-2024)
Table 67. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2024-2029)
Table 68. Global Anti Influenza Virus Chinese Medicine Price (US$/Ton) by Application (2018-2024)
Table 69. Global Anti Influenza Virus Chinese Medicine Price (US$/Ton) by Application (2024-2029)
Table 70. Guangzhou Pharmaceutical Corporation Information
Table 71. Guangzhou Pharmaceutical Description and Business Overview
Table 72. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 73. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 74. Guangzhou Pharmaceutical Recent Developments/Updates
Table 75. CR SANJIU Corporation Information
Table 76. CR SANJIU Description and Business Overview
Table 77. CR SANJIU Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 78. CR SANJIU Anti Influenza Virus Chinese Medicine Product
Table 79. CR SANJIU Recent Developments/Updates
Table 80. TASLY Corporation Information
Table 81. TASLY Description and Business Overview
Table 82. TASLY Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 83. TASLY Anti Influenza Virus Chinese Medicine Product
Table 84. TASLY Recent Developments/Updates
Table 85. China TCM Corporation Information
Table 86. China TCM Description and Business Overview
Table 87. China TCM Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 88. China TCM Anti Influenza Virus Chinese Medicine Product
Table 89. China TCM Recent Developments/Updates
Table 90. Yunnan Baiyao Corporation Information
Table 91. Yunnan Baiyao Description and Business Overview
Table 92. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 93. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product
Table 94. Yunnan Baiyao Recent Developments/Updates
Table 95. Tongrentang Corporation Information
Table 96. Tongrentang Description and Business Overview
Table 97. Tongrentang Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 98. Tongrentang Anti Influenza Virus Chinese Medicine Product
Table 99. Tongrentang Recent Developments/Updates
Table 100. Jumpcan Corporation Information
Table 101. Jumpcan Description and Business Overview
Table 102. Jumpcan Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 103. Jumpcan Anti Influenza Virus Chinese Medicine Product
Table 104. Jumpcan Recent Developments/Updates
Table 105. Zhejiang Conba Pharmaceutical Corporation Information
Table 106. Zhejiang Conba Pharmaceutical Description and Business Overview
Table 107. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 108. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 109. Zhejiang Conba Pharmaceutical Recent Developments/Updates
Table 110. Green Valley Pharma Corporation Information
Table 111. Green Valley Pharma Description and Business Overview
Table 112. Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 113. Green Valley Pharma Anti Influenza Virus Chinese Medicine Product
Table 114. Green Valley Pharma Recent Developments/Updates
Table 115. Changbaishan Pharmaceutical Corporation Information
Table 116. Changbaishan Pharmaceutical Description and Business Overview
Table 117. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 118. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 119. Changbaishan Pharmaceutical Recent Developments/Updates
Table 120. Zhejiang Kanglaite Pharmaceutical Corporation Information
Table 121. Zhejiang Kanglaite Pharmaceutical Description and Business Overview
Table 122. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 123. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 124. Zhejiang Kanglaite Pharmaceutical Recent Developments/Updates
Table 125. Qingfeng Pharmaceutical Group Corporation Information
Table 126. Qingfeng Pharmaceutical Group Description and Business Overview
Table 127. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 128. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product
Table 129. Qingfeng Pharmaceutical Group Recent Developments/Updates
Table 130. Buchang Pharmaceutical Corporation Information
Table 131. Buchang Pharmaceutical Description and Business Overview
Table 132. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 133. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 134. Buchang Pharmaceutical Recent Developments/Updates
Table 135. Livzon Corporation Information
Table 136. Livzon Description and Business Overview
Table 137. Livzon Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 138. Livzon Anti Influenza Virus Chinese Medicine Product
Table 139. Livzon Recent Developments/Updates
Table 140. ZBD Pharmaceutical Corporation Information
Table 141. ZBD Pharmaceutical Description and Business Overview
Table 142. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 143. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 144. ZBD Pharmaceutical Recent Developments/Updates
Table 145. Chase Sun Pharmaceutical Corporation Information
Table 146. Chase Sun Pharmaceutical Description and Business Overview
Table 147. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 148. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 149. Chase Sun Pharmaceutical Recent Developments/Updates
Table 150. Wuzhou Pharmaceutical Corporation Information
Table 151. Wuzhou Pharmaceutical Description and Business Overview
Table 152. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 153. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 154. Wuzhou Pharmaceutical Recent Developments/Updates
Table 155. Yusheng Pharmaceutical Corporation Information
Table 156. Yusheng Pharmaceutical Description and Business Overview
Table 157. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 158. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 159. Yusheng Pharmaceutical Recent Developments/Updates
Table 160. Harbin Pharmaceutical Group Corporation Information
Table 161. Harbin Pharmaceutical Group Description and Business Overview
Table 162. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 163. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product
Table 164. Harbin Pharmaceutical Group Recent Developments/Updates
Table 165. Fusen Pharmaceutical Corporation Information
Table 166. Fusen Pharmaceutical Description and Business Overview
Table 167. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 168. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 169. Fusen Pharmaceutical Recent Developments/Updates
Table 170. Gerun Pharmaceutical Corporation Information
Table 171. Gerun Pharmaceutical Description and Business Overview
Table 172. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 173. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 174. Gerun Pharmaceutical Recent Developments/Updates
Table 175. Shineway Pharmaceutical Corporation Information
Table 176. Shineway Pharmaceutical Description and Business Overview
Table 177. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 178. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 179. Shineway Pharmaceutical Recent Developments/Updates
Table 180. Yiling Pharmaceutical Corporation Information
Table 181. Yiling Pharmaceutical Description and Business Overview
Table 182. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 183. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product
Table 184. Yiling Pharmaceutical Recent Developments/Updates
Table 185. Harbin Pharmaceutical Group Corporation Information
Table 186. Harbin Pharmaceutical Group Description and Business Overview
Table 187. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 188. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product
Table 189. Harbin Pharmaceutical Group Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Anti Influenza Virus Chinese Medicine Distributors List
Table 193. Anti Influenza Virus Chinese Medicine Customers List
Table 194. Anti Influenza Virus Chinese Medicine Market Trends
Table 195. Anti Influenza Virus Chinese Medicine Market Drivers
Table 196. Anti Influenza Virus Chinese Medicine Market Challenges
Table 197. Anti Influenza Virus Chinese Medicine Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti Influenza Virus Chinese Medicine
Figure 2. Global Anti Influenza Virus Chinese Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Anti Influenza Virus Chinese Medicine Market Share by Type in 2022 & 2029
Figure 4. Oral Solution Product Picture
Figure 5. Capsule Product Picture
Figure 6. Lozenges Product Picture
Figure 7. Chewable Tablets Product Picture
Figure 8. Aerosol Product Picture
Figure 9. Injection Product Picture
Figure 10. Pills Product Picture
Figure 11. Particles Product Picture
Figure 12. Syrup Product Picture
Figure 13. Global Anti Influenza Virus Chinese Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 14. Global Anti Influenza Virus Chinese Medicine Market Share by Application in 2022 & 2029
Figure 15. Adult
Figure 16. Children
Figure 17. Global Anti Influenza Virus Chinese Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Anti Influenza Virus Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 19. Global Anti Influenza Virus Chinese Medicine Sales (2018-2029) & (Kiloton)
Figure 20. Global Anti Influenza Virus Chinese Medicine Average Price (US$/Ton) & (2018-2029)
Figure 21. Anti Influenza Virus Chinese Medicine Report Years Considered
Figure 22. Anti Influenza Virus Chinese Medicine Sales Share by Manufacturers in 2022
Figure 23. Global Anti Influenza Virus Chinese Medicine Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Anti Influenza Virus Chinese Medicine Players: Market Share by Revenue in 2022
Figure 25. Anti Influenza Virus Chinese Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Anti Influenza Virus Chinese Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2018-2029)
Figure 28. North America Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2018-2029)
Figure 29. United States Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Canada Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2018-2029)
Figure 32. Europe Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2018-2029)
Figure 33. Germany Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2018-2029)
Figure 39. Asia Pacific Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2018-2029)
Figure 40. China Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2018-2029)
Figure 50. Latin America Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Sales Market Share of Anti Influenza Virus Chinese Medicine by Type (2018-2029)
Figure 60. Global Revenue Market Share of Anti Influenza Virus Chinese Medicine by Type (2018-2029)
Figure 61. Global Anti Influenza Virus Chinese Medicine Price (US$/Ton) by Type (2018-2029)
Figure 62. Global Sales Market Share of Anti Influenza Virus Chinese Medicine by Application (2018-2029)
Figure 63. Global Revenue Market Share of Anti Influenza Virus Chinese Medicine by Application (2018-2029)
Figure 64. Global Anti Influenza Virus Chinese Medicine Price (US$/Ton) by Application (2018-2029)
Figure 65. Anti Influenza Virus Chinese Medicine Value Chain
Figure 66. Anti Influenza Virus Chinese Medicine Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed